Wyniki wyszukiwania

1

Arterial angioplasty. Thrombosis and restenosis

100%

Badimon L., Chesebro J. H., Badimon J. J., Fuster V.

Journal of Physiology and Pharmacology. Supplement

|

1993

|

tom 44

|

nr 2

2

Development of liposomal gene targeting for therapeutic intervention or prevention of restenosis

100%

Zant-Przeworska E., Kamps J. A. A. M., Roks A. J. M., Van Gilst W. H., Scherphof G. L.

Cellular and Molecular Biology Letters

|

2002

|

tom 07

|

nr 2

3

A new face of endocannabinoids in pharmacotherapy. Part II: Role of endocannabinoids in inflammation-derived cardiovascular diseases infarction

84%

Zubrzycki M., Liebold A., Janecka A., Zubrzycka M.

Journal of Physiology and Pharmacology

|

2014

|

tom 65

|

nr 2

4

Helicobacter pylori infection in coronary artery disease

84%

Kowalski M., Pawlik M., Konturek J. W., Konturek S. J.

Journal of Physiology and Pharmacology. Supplement

|

2006

|

tom 57

|

nr 3

101-111

The role of inflammation in the pathogenesis and progression of coronary artery disease (CAD) has been increasingly discussed, but still remains unclear. Inflammatory changes in the vessel wall play an important role in the pathogenesis of atherosclerosis. Systemic inflammatory reaction can be detected by showing increased plasma levels of different proinflammatory cytokines and acute-phase proteins. Infectious agents have been linked to coronary heart disease on epidemiological and pathogenetic grounds. The prevalent condition and the exact mechanism of initiation of atherosclerotic vascular disease remain unclear. Nevertheless, many similarities exist between the processes of inflammation and atherogenesis, and the evidence is growing for the role of an active inflammation in the atherosclerosis in the coronary circulation and elsewhere. Although the seroepidemiological and eradication studies have suggested a causal relationship between Helicobacter pylori (Hp) infection and coronary heart disease; the issue is still controversial. The detection of Hp specific DNA in atheromatous plaque material from coronary arteries, but more important, the reduction in restenosis of coronary vessels after Hp eradication could be interpreted as an evidence for the involvement of a Hp infection in the progression of CAD induced by a local inflammatory process.

5

The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study

84%

Korybalska K., Kawka E., Breborowicz A., Witkowski J.

Journal of Physiology and Pharmacology

|

2017

|

tom 68

|

nr 3

6

Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction

84%

Tendera M., Wojakowski W.

Folia Histochemica et Cytobiologica

|

2005

|

tom 43

|

nr 4

7

Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik

Influence of diethylenetriamine [DETA] and sodium nitroprusside [NaNP] on sister chromatid exchange frequency and cell kinetics in cultured human lymphocytes

84%

Perkowska M., Szczygiel M., Wozniak A., Limon J.

Journal of Applied Genetics

|

2001

|

tom 42

|

nr 2

8

In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells

67%

Wawrzynska M., Kalas W., Bialy D., Ziolo E., Arkowski J., Mazurek W., Strzadala L.

Archivum Immunologiae et Therapiae Experimentalis

|

2010

|

tom 58

|

nr 1

67-75

9

Development and applications of PDGF antagonists

67%

Ostman A., Miyazawa K., Leppanen O., Pietras K., Sjoblom T., Shimizu B., Perrson C., Backstrom G., Dumanski J., O'Brien K., Jaccic N., Heldin C. H.

Cellular and Molecular Biology Letters

|

1998

|

tom 03

|

nr 3

10

Genetic approaches for prevention of restenosis following percutaneous translumenal angioplasty

67%

Pirog E. C.

Bulletin of the Polish Academy of Sciences. Biological Sciences

|

1994

|

tom 42

|

nr 4

Ograniczanie wyników

Arterial angioplasty. Thrombosis and restenosis

Development of liposomal gene targeting for therapeutic intervention or prevention of restenosis

A new face of endocannabinoids in pharmacotherapy. Part II: Role of endocannabinoids in inflammation-derived cardiovascular diseases infarction

Helicobacter pylori infection in coronary artery disease

The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study

Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction

Influence of diethylenetriamine [DETA] and sodium nitroprusside [NaNP] on sister chromatid exchange frequency and cell kinetics in cultured human lymphocytes

In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells

Development and applications of PDGF antagonists

Genetic approaches for prevention of restenosis following percutaneous translumenal angioplasty